! Physiological and molecular effects of interleukin-18 administration on the mouse kidney
Authors:
- Kyosuke YamanishiKyosuke Yamanishi
- Keiichiro MukaiKMKeiichiro Mukai
- Takuya HashimotoTHTakuya Hashimoto
- Kaoru IkuboKIKaoru Ikubo
- Keiji NakashoKNKeiji Nakasho
- Yosif El-DarawishYEYosif El-Darawish
- Wen LiWLWen Li
- Daisuke OkuzakiDODaisuke Okuzaki
- Yuko WatanabeYWYuko Watanabe
- Tetsu HayakawaTHTetsu Hayakawa
- Hiroshi NojimaHNHiroshi Nojima
- Hiromichi YamanishiHYHiromichi Yamanishi
Open Access
- 7 March 2018
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 16 (1) , 1-9
Abstract
Background: The cytokine interleukin-18 was originally identified as an interferon-gamma-inducing proinflammatory factor; however, there is increasing evidence to suggest that it has non-immunological effects on physiological functions. We previously investigated the potential pathophysiological relationship between interleukin-18 and dyslipidemia, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis, and suggested interleukin-18 as a possible novel treatment for not only these diseases but also for cancer immunotherapy. Before clinical application, the effects of interleukin-18 on the kidney need to be determined. In the current study, we examined the kidney of interleukin-18 knockout (Il18(-/-)) mice and the effects of interleukin-18 on the kidney following intravenous administration of recombinant interleukin-18. Methods: Il18(-/-) male mice were generated on the C57Bl/6 background and littermate C57Bl/6 Il18(+/+) male mice were used as controls. To assess kidney damage, serum creatinine and blood urea nitrogen levels were measured and histopathological analysis was performed. For molecular analysis, microarray and quantitative reverse transcription PCR was performed using mice 6 and 12 weeks old. To evaluate the short-and long-term effects of interleukin-18 on the kidney, recombinant interleukin-18 was administered for 2 and 12 weeks, respectively. Results: Compared with Il18(+/+) mice, Il18(-/-) mice developed kidney failure in their youth-6 weeks of age, but the condition was observed to improve as the mice aged, even though dyslipidemia, arteriosclerosis, and higher insulin resistance occurred. Analyses of potential molecular mechanisms involved in the onset of early kidney failure in Il18(-/-) mice identified a number of associated genes, such as Itgam, Nov, and Ppard. Intravenous administration of recombinant interleukin-18 over both the short and long term showed no effects on the kidney despite significant improvement in metabolic diseases. Conclusions: Short- and long-term administration of interleukin-18 appeared to have no adverse effects on the kidney in these mice, suggesting that administration may be a safe and novel treatment for metabolic diseases and cancer.Keywords
This publication has 41 references indexed in Scilit:
- Polymorphisms inPPARGenes (PPARD,PPARG, andPPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC StudyPPAR Research, 2013
- Licofelone Inhibits Interleukin‐18‐Induced Pro‐Inflammatory Cytokine Release and Cellular Proliferation in Human Mesangial CellsBasic & Clinical Pharmacology & Toxicology, 2012
- Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factorsJournal of Clinical Investigation, 2011
- Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteinsJournal of Translational Medicine, 2011
- Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndromeNutrition & Metabolism, 2011
- Distinct Roles for Basal and Induced COX-2 in Podocyte InjuryJournal of the American Society of Nephrology, 2009
- Effects of receptor-mediated endocytosis and tubular protein composition on volume retention in experimental glomerulonephritisAmerican Journal of Physiology-Renal Physiology, 2009
- TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cellsKidney International, 2006
- Projecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015Journal of the American Society of Nephrology, 2005
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995